Other grades of this product :
| myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse Basic information |
| Product Name: | myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse | | Synonyms: | Deoxyribonucleic acid (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying);DNA (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying cDNA);DNA (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying);Myelin oligodendrocyte glycoprotein mouse rat 35-55;MOG 35-55 amide;Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55 Rat, Mouse immunodominant epitope of MOG | | CAS: | 163913-87-9 | | MF: | C118H177N35O29S | | MW: | 0 | | EINECS: | | Product Categories: | | Mol File: | Mol File |
| myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse Chemical Properties |
| storage temp. | -20°C | | form | White to off-white powder. |
| myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse Usage And Synthesis |
| General Description | Myelin oligodendrocyte glycoprotein (MOG) is a component of the central nervous system and present on the surface of oligodendrocytes and myelin. Its extracellular domain is widely used to generate an autoimmune animal model of multiple sclerosis. In rats, it is expressed in the hippocampus. | | Biochem/physiol Actions | Induces experimental autoimmune encephalomyelitis in rodents; a single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination; immunization with MOG (35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. |
| myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse Preparation Products And Raw materials |
|